Log in
CNSX:BTH

179171 Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume101,838 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Breathtec Biomedical, Inc., through its subsidiary, Nash Pharmaceuticals Inc., focuses on drug repurposing in the areas of non-alcoholic steatohepatitis, chronic kidney, and inflammatory bowel diseases. Its lead compound is the NP-178 for use in the treatment of ulcerative colitis. The company also develops NP-120 that is clinically used for the treatment of ulcerative colitis and Crohn's diseases. Breathtec Biomedical, Inc. is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive BTH News and Ratings via Email

Sign-up to receive the latest news and ratings for BTH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











179171 (CNSX:BTH) Frequently Asked Questions

What stocks does MarketBeat like better than 179171?

Wall Street analysts have given 179171 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 179171 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of 179171's key competitors?

Who are 179171's key executives?

179171's management team includes the following people:
  • Mr. Michael S. M. Sadhra CA, CPA, CFO & Director (Age 50)
  • Dr. Michael T. Costanzo Ph.D., Chief Technical Officer (Age 30)
  • Mr. Alfred Wong, VP of Corp. Devel. & Communications
  • Mr. Christopher J. Moreau, Chief Exec. Officer
  • Colin Trethewey, Exec.

What is 179171's stock symbol?

179171 trades on the CNSX under the ticker symbol "BTH."

What is 179171's official website?

The official website for 179171 is www.breathtecbiomedical.com.

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.